PACB — Pacific Biosciences Of California Cashflow Statement
0.000.00%
Last trade - 00:00- $555.51m
- $902.01m
- $154.01m
Annual cashflow statement for Pacific Biosciences Of California, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | 10-K | 10-K | 10-K | 10-K | |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -181 | -314 | -307 | -310 | — |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 135 | 94.6 | 98.2 | 103 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 21 | -54 | -59 | -40.6 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -111 | -263 | -259 | -206 | — |
| Capital Expenditures | -5.93 | -16.9 | -8.84 | -6.19 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -673 | 133 | 13.4 | 130 | — |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -679 | 116 | 4.6 | 124 | — |
| Financing Cash Flow Items | -52.2 | — | -93.8 | -50.2 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,170 | 9.62 | 109 | -43 | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 380 | -138 | -146 | -125 | — |